Investment analysts at Leerink Partnrs lifted their FY2024 earnings per share (EPS) estimates for shares of OmniAb in a report released on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now ...

Investment analysts at Zacks Research cut their FY2025 earnings estimates for Zoetis in a research report issued on Wednesday ...

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit and maintained its annual ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a public offering ...

Notable insider trades include Schobel Alexander Mark, Chief Innovation/Tech Officer at Aquestive Therapeutics Inc (AQST), who sold 50000 shares on Mar 15 ’24, at $6 each, totaling $0.30 million. On ...

NEWPORT BEACH, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- , LLC (“ROTH”), announced today the addition of five ...

On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...

In a report released today, Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – Research ...

Envista Holdings Corp (NVST) stock saw a decline, ending the day at $19.17 which represents a decrease of $-0.32 or -1.64% from the prior close of $19.49. The stock opened at $19.42 and touched a low ...

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit and maintained its annual ...

Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock. Amylyx intends to ...